Danimer Scientific, Inc. (NYSE:DNMR) – Analysts at Jefferies Financial Group upped their FY2021 earnings per share (EPS) estimates for shares of Danimer Scientific in a research note issued on Monday, November 22nd. Jefferies Financial Group analyst L. Alexander now expects that the company will post earnings of ($0.17) per share for the year, up from their prior forecast of ($0.21). Jefferies Financial Group has a “Buy” rating and a $30.00 price objective on the stock. Jefferies Financial Group also issued estimates for Danimer Scientific’s Q4 2021 earnings at ($0.07) EPS, FY2022 earnings at ($0.35) EPS and FY2023 earnings at ($0.25) EPS.
Other analysts have also issued reports about the stock. Cowen initiated coverage on shares of Danimer Scientific in a research report on Thursday, September 23rd. They set an “outperform” rating and a $21.00 target price on the stock. Zacks Investment Research upgraded shares of Danimer Scientific from a “sell” rating to a “hold” rating in a research report on Wednesday.
In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of the business’s stock in a transaction dated Wednesday, November 17th. The shares were sold at an average price of $15.54, for a total value of $155,400.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders sold 30,000 shares of company stock worth $460,200. Company insiders own 14.90% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in DNMR. Stifel Financial Corp bought a new position in shares of Danimer Scientific in the first quarter worth about $227,000. Ameriprise Financial Inc. bought a new position in shares of Danimer Scientific in the first quarter worth about $2,109,000. Price T Rowe Associates Inc. MD bought a new position in shares of Danimer Scientific in the first quarter worth about $4,150,000. Royal Bank of Canada raised its stake in shares of Danimer Scientific by 144.6% in the first quarter. Royal Bank of Canada now owns 45,281 shares of the company’s stock worth $1,709,000 after acquiring an additional 26,766 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC bought a new position in shares of Danimer Scientific in the first quarter worth about $238,000. 46.67% of the stock is owned by institutional investors.
About Danimer Scientific
Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petrochemical-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including water bottles, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.
Featured Story: How to invest using market indexes
Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.